A Nature research paper reports reduced effectiveness of vaccine- or infection-elicited antibodies against the SARS-CoV-2 Omicon variant, relative to other viral lineages
and is provided in this format here as a response to the exceptional public-health crisis. This accepted manuscript will continue through the processes of copy editing and formatting to publication of a finalized version of record on nature.com. Please note there may be errors present in this version, which may affect the content, and all legal disclaimers apply.
The Omicron variant of severe acute respiratory syndrome coronavirus 2 was initially identified in November of 2021 in South Africa and Botswana as well as in a sample from a traveler from South Africa in Hong Kong. Since then, B.1.1.529 has been detected globally. This variant seems to be at least equally infectious than B.1.617.2 , has already caused super spreader eventsand has outcompeted Delta within weeks in several countries and metropolitan areas. B.1.1.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronA Nature research paper reports reduced effectiveness of vaccine- or infection-elicited antibodies against the SARS-CoV-2 Omicon variant, relative to other viral lineages
Lire la suite »
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern AfricaNature research paper: Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Lire la suite »
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern AfricaNature research paper: Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Lire la suite »
Cypriot Researchers Reports New SARS-CoV-2 Variant, a Mix of Delta and OmicronA research team at the University of Cyprus has identified a new COVID-19 variant in 25 cases where the virus has signatures of both the Delta as well as the Omicron variants.
Lire la suite »
Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronA Nature research paper reports reduced effectiveness of vaccine- or infection-elicited antibodies against the SARS-CoV-2 Omicon variant, relative to other viral lineages
Lire la suite »
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern AfricaNature research paper: Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Lire la suite »